BMRA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biomerica Inc (BMRA).


$9.77M Market Cap.

As of 08/29/2024 5:00 PM ET (MRY) • Disclaimer

BMRA Market Cap. (MRY)


BMRA Shares Outstanding (MRY)


BMRA Assets (MRY)


Total Assets

$9.25M

Total Liabilities

$2.66M

Total Investments

$165.00K

BMRA Income (MRY)


Revenue

$5.42M

Net Income

-$5.98M

Operating Expense

$6.98M

BMRA Cash Flow (MRY)


CF Operations

-$5.36M

CF Investing

-$115.00K

CF Financing

-$81.00K

BMRA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BMRA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$9,254,000 (-35.98%)

$14,454,000 (27.08%)

$11,374,000 (-3.76%)

$11,818,813 (-31.52%)

Assets Current

$7,731,000 (-39.59%)

$12,797,000 (35.75%)

$9,427,000 (2.12%)

$9,230,907 (-37.49%)

Assets Non-Current

$1,523,000 (-8.09%)

$1,657,000 (-14.89%)

$1,947,000 (-24.77%)

$2,587,906 (3.80%)

Goodwill & Intangible Assets

$212,000 (28.48%)

$165,000 (-2.94%)

$170,000 (-42.34%)

$294,830 (74.81%)

Shareholders Equity

$6,591,000 (-43.78%)

$11,724,000 (40.83%)

$8,325,000 (-9.78%)

$9,227,023 (-35.08%)

Property Plant & Equipment Net

$943,000 (-24.44%)

$1,248,000 (-17.68%)

$1,516,000 (-18.65%)

$1,863,601 (-6.39%)

Cash & Equivalents

$4,170,000 (-57.09%)

$9,719,000 (64.26%)

$5,917,000 (40.90%)

$4,199,311 (-51.40%)

Accumulated Other Comprehensive Income

-$102,000 (7.27%)

-$110,000 (-48.65%)

-$74,000 (-54.31%)

-$47,956 (-20.37%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$165,000 (0.00%)

$165,000 (0.00%)

$165,000 (-0.20%)

$165,324 (0.00%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$165,000 (0.00%)

$165,000 (0.00%)

$165,000 (-0.20%)

$165,324 (0.00%)

Inventory

$2,376,000 (15.56%)

$2,056,000 (-14.90%)

$2,416,000 (-24.65%)

$3,206,255 (12.47%)

Trade & Non-Trade Receivables

$947,000 (31.16%)

$722,000 (-6.72%)

$774,000 (-46.81%)

$1,455,051 (-17.60%)

Trade & Non-Trade Payables

$1,138,000 (27.58%)

$892,000 (-8.23%)

$972,000 (66.62%)

$583,380 (-40.88%)

Accumulated Retained Earnings (Deficit)

-$48,195,000 (-14.16%)

-$42,217,000 (-20.36%)

-$35,077,000 (-14.83%)

-$30,546,335 (-32.23%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$785,000 (-27.45%)

$1,082,000 (-21.54%)

$1,379,000 (6.77%)

$1,291,570 (-17.72%)

Debt Current

$326,000 (9.76%)

$297,000 (-12.90%)

$341,000 (0%)

$0 (0%)

Debt Non-Current

$459,000 (-41.53%)

$785,000 (-24.37%)

$1,038,000 (-19.63%)

$1,291,570 (-17.72%)

Total Liabilities

$2,663,000 (-2.45%)

$2,730,000 (-10.46%)

$3,049,000 (17.64%)

$2,591,790 (-14.93%)

Liabilities Current

$2,204,000 (13.32%)

$1,945,000 (-3.28%)

$2,011,000 (54.67%)

$1,300,220 (-11.98%)

Liabilities Non-Current

$459,000 (-41.53%)

$785,000 (-24.37%)

$1,038,000 (-19.63%)

$1,291,570 (-17.72%)

BMRA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$5,415,000 (1.42%)

$5,339,000 (-71.71%)

$18,871,000 (162.13%)

$7,199,027 (7.57%)

Cost of Revenue

$4,804,000 (-1.82%)

$4,893,000 (-69.21%)

$15,894,000 (132.62%)

$6,832,742 (37.91%)

Selling General & Administrative Expense

$5,487,000 (-9.83%)

$6,085,000 (6.77%)

$5,699,000 (0.48%)

$5,671,517 (122.71%)

Research & Development Expense

$1,491,000 (-5.87%)

$1,584,000 (-12.58%)

$1,812,000 (-17.43%)

$2,194,461 (13.55%)

Operating Expenses

$6,978,000 (-9.01%)

$7,669,000 (2.10%)

$7,511,000 (-4.51%)

$7,865,978 (75.61%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$367 (3977.78%)

Income Tax Expense

$42,000 (-17.65%)

$51,000 (112.50%)

$24,000 (83.81%)

$13,057 (76.68%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,978,000 (16.27%)

-$7,140,000 (-57.58%)

-$4,531,000 (39.15%)

-$7,446,254 (-178.14%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,978,000 (16.27%)

-$7,140,000 (-57.58%)

-$4,531,000 (39.15%)

-$7,446,254 (-178.14%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,978,000 (16.27%)

-$7,140,000 (-57.58%)

-$4,531,000 (39.15%)

-$7,446,254 (-178.14%)

Weighted Average Shares

$16,821,646 (18.85%)

$14,154,269 (11.69%)

$12,673,245 (6.24%)

$11,928,941 (17.34%)

Weighted Average Shares Diluted

$16,821,646 (18.85%)

$14,154,269 (11.69%)

$12,673,245 (6.24%)

$11,928,941 (17.34%)

Earning Before Interest & Taxes (EBIT)

-$5,936,000 (16.26%)

-$7,089,000 (-57.29%)

-$4,507,000 (39.36%)

-$7,432,830 (-178.41%)

Gross Profit

$611,000 (37.00%)

$446,000 (-85.02%)

$2,977,000 (712.76%)

$366,285 (-78.93%)

Operating Income

-$6,367,000 (11.85%)

-$7,223,000 (-59.31%)

-$4,534,000 (39.54%)

-$7,499,693 (-173.62%)

BMRA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$115,000 (-47.44%)

-$78,000 (54.12%)

-$170,000 (42.49%)

-$295,583 (-148.54%)

Net Cash Flow from Financing

-$81,000 (-100.86%)

$9,390,000 (292.23%)

$2,394,000 (114.95%)

$1,113,730 (-91.00%)

Net Cash Flow from Operations

-$5,361,000 (2.06%)

-$5,474,000 (-1042.80%)

-$479,000 (90.88%)

-$5,251,748 (-22.20%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,549,000 (-245.95%)

$3,802,000 (121.18%)

$1,719,000 (138.70%)

-$4,441,716 (-155.84%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$51,000 (20.31%)

-$64,000 (-12.28%)

-$57,000 (58.04%)

-$135,856 (-304.24%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$10,095,000 (307.22%)

$2,479,000 (93.72%)

$1,279,649 (-87.76%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$8,000 (122.22%)

-$36,000 (-38.46%)

-$26,000 (-220.39%)

-$8,115 (-145.17%)

Share Based Compensation

$837,000 (-29.37%)

$1,185,000 (-5.95%)

$1,260,000 (-6.98%)

$1,354,609 (151.51%)

Depreciation Amortization & Accretion

$374,000 (6.55%)

$351,000 (-41.01%)

$595,000 (58.31%)

$375,855 (-5.71%)

BMRA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

11.30% (34.52%)

8.40% (-46.84%)

15.80% (209.80%)

5.10% (-80.38%)

Profit Margin

-110.40% (17.43%)

-133.70% (-457.08%)

-24.00% (76.79%)

-103.40% (-158.50%)

EBITDA Margin

-102.70% (18.62%)

-126.20% (-509.66%)

-20.70% (78.88%)

-98.00% (-189.09%)

Return on Average Equity (ROAE)

-69.20% (19.35%)

-85.80% (-69.57%)

-50.60% (26.02%)

-68.40% (-65.22%)

Return on Average Assets (ROAA)

-53.60% (18.17%)

-65.50% (-99.70%)

-32.80% (38.81%)

-53.60% (-96.34%)

Return on Sales (ROS)

-109.60% (17.47%)

-132.80% (-455.65%)

-23.90% (76.84%)

-103.20% (-158.65%)

Return on Invested Capital (ROIC)

-157.90% (12.57%)

-180.60% (-56.50%)

-115.40% (-23.16%)

-93.70% (-129.10%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.61 (41.13%)

-2.74 (71.82%)

-9.72 (-65.14%)

-5.89 (76.34%)

Price to Sales Ratio (P/S)

1.8 (-50.33%)

3.63 (54.49%)

2.35 (-61.13%)

6.05 (-38.46%)

Price to Book Ratio (P/B)

1.48 (-24.62%)

1.97 (-63.61%)

5.4 (11.04%)

4.87 (-5.44%)

Debt to Equity Ratio (D/E)

0.4 (73.39%)

0.23 (-36.34%)

0.37 (30.25%)

0.28 (31.31%)

Earnings Per Share (EPS)

-0.36 (28.00%)

-0.5 (-38.89%)

-0.36 (41.94%)

-0.62 (-138.46%)

Sales Per Share (SPS)

0.32 (-14.59%)

0.38 (-74.68%)

1.49 (146.93%)

0.6 (-8.36%)

Free Cash Flow Per Share (FCFPS)

-0.32 (17.65%)

-0.39 (-830.95%)

-0.04 (90.71%)

-0.45 (-6.10%)

Book Value Per Share (BVPS)

0.39 (-52.66%)

0.83 (26.03%)

0.66 (-15.01%)

0.77 (-44.71%)

Tangible Assets Book Value Per Share (TABVPS)

0.54 (-46.73%)

1.01 (14.25%)

0.88 (-8.49%)

0.97 (-42.53%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (66.67%)

-3 (62.50%)

-8 (-33.33%)

-6 (77.78%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.95 (68.66%)

-3.05 (66.81%)

-9.18 (-57.89%)

-5.81 (81.76%)

Asset Turnover

0.48 (-1.02%)

0.49 (-64.13%)

1.37 (163.20%)

0.52 (-23.90%)

Current Ratio

3.51 (-46.68%)

6.58 (40.34%)

4.69 (-33.96%)

7.1 (-28.99%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$5,412,000 (2.28%)

-$5,538,000 (-933.21%)

-$536,000 (90.05%)

-$5,387,604 (-24.39%)

Enterprise Value (EV)

$5,309,648 (-74.14%)

$20,529,387 (-42.84%)

$35,912,537 (-12.46%)

$41,026,475 (-43.32%)

Earnings Before Tax (EBT)

-$5,936,000 (16.26%)

-$7,089,000 (-57.29%)

-$4,507,000 (39.37%)

-$7,433,197 (-178.42%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,562,000 (17.45%)

-$6,738,000 (-72.24%)

-$3,912,000 (44.57%)

-$7,056,975 (-210.72%)

Invested Capital

$3,453,000 (-6.85%)

$3,707,000 (-20.37%)

$4,655,000 (-36.37%)

$7,316,022 (-14.36%)

Working Capital

$5,527,000 (-49.07%)

$10,852,000 (46.33%)

$7,416,000 (-6.49%)

$7,930,687 (-40.32%)

Tangible Asset Value

$9,042,000 (-36.72%)

$14,289,000 (27.53%)

$11,204,000 (-2.78%)

$11,523,983 (-32.57%)

Market Capitalization

$9,766,648 (-57.62%)

$23,045,655 (-48.77%)

$44,981,734 (0.18%)

$44,902,873 (-38.61%)

Average Equity

$8,637,500 (3.83%)

$8,318,649 (-7.02%)

$8,946,821 (-17.84%)

$10,889,003 (68.21%)

Average Assets

$11,161,500 (2.35%)

$10,905,447 (-21.06%)

$13,814,875 (-0.50%)

$13,884,189 (41.54%)

Invested Capital Average

$3,758,250 (-4.25%)

$3,925,077 (0.54%)

$3,904,131 (-50.80%)

$7,935,928 (21.63%)

Shares

16,821,646 (0.00%)

16,821,646 (30.89%)

12,851,924 (4.47%)

12,302,157 (8.82%)